BibTex RIS Cite

Çocukluk Çağında Şilotoraks; Üç Olgu Sunumu, Güncel Tanı ve Tedavi Yaklaşımları

Year 2015, Volume: 9 Issue: 3, 219 - 225, 01.08.2015

Abstract

Şilotoraks, çocukluk çağında plevral efüzyonun nadir bir nedenidir. Hastalığın etiyolojisi yaşa göre değişmekle birlikte, başlıca nedenler; konjenital nedenler, cerrahi işlemler, travma, tümöral nedenler, idiyopatik ve bazı enfeksiyöz hastalıkları olarak bildirilmektedir. Klinik bulgular, radyolojik bulgular ve plevral sıvının analiziyle şilotoraks tanısı konulan üç çocuk olgu; iki buçuk aylık kız hasta (idiyopatik “non-immun” hidrops fetalis ilişkili konjenital şilotoraks), üç buçuk aylık erkek hasta (idiyopatik şilotoraks) ve on bir aylık erkek hasta (idiyopatik şilotoraks) sunuldu. Hastaların üçü de toraks tüpü ile drenaja ek olarak medikal tedavi (Olgu 1; total parenteral nutrisyon ve orta zincirli yağ asiti içeren formul mama, Olgu 2; total parenteral nutrisyon, orta zincirli yağ asiti içeren formul mama ve somatostatin, Olgu 3; orta zincirli yağ asiti içeren formul mama) ile tedavi edildi. Her üç olguda da tedavi sonrası izlem dönemlerinde nüks görülmedi. Şilotoraks tanısı klinik bulgular, radyoloji ve plevral sıvının analizi ile konulmaktadır. Diyet ve total parenteral nutrisyon tedavilerine yanıt alınamayan olgularda somatostatin veya oktreotid tedavisinin eklenmesiyle ile iyi sonuç alınabilmektedir. Medikal tedaviye dirençli olgularda cerrahi tedavi uygulanabilmektedir.

References

  • Eddiernan KA, Levine AB, Chitkara U, Berkowitz RL. Reliability of pleural fluid lymphocyte counts in the antenatal diagnosis of congenital chylothorax. Obstet Gynecol 1991;178:530-2.
  • Tutor JD. Chylothorax in Infants and Children. Pediatrics 2014;133:722-33.
  • Soto-Martinez M, Massie J. Chylothorax: Diagnosis and manage- ment in children. Paediatr Respir Rev 2009;10:199-207.
  • McGrath EE, Blades Z, Anderson PB. Chylothorax: Aetiology, diagnosis and therapeutic options. Respir Med 2010;104:1-8.
  • Paramés F, Freitas I, Fragata J, Trigo C, Pinto MF. Octreotide additional conservative therapy for postoperative chylothorax in congenital heart disease. Rev Port Cardiol 2009;28:799-807.
  • Chernick V, Reed MH. Pneumothorax and chylothorax in the neonatal period. J Pediatr 1970;76:624-32.
  • Fukushima K, Morokuma S, Fujita Y, Tsukimori K, Satoh S, Ochiai M, et al. Short-term and long-term outcomes of 214 cases of non- immune hydrops fetalis. Early Hum Dev 2011;87:571-5.
  • Çelik Y, Akbaş B, Mimaroğlu E, Taşkınlar H, Ali Arslanköylü AE, Hallıoğlu O. Hidrops fetalis ile birlikte nedeni bilinmeyen doğumsal şilotoraks. Çocuk 2013;13:70-2.
  • Faul JL, Berry GJ, Colby TV, Ruoss SJ, Walter MB, Rosen GD, et al. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med 2000;161:1037-46.
  • Higgins JN, Shah AR, Dicks-Mireaux CF, Conry BG. Case report: Computed tomography of generalized lymphangiomatosis and chylothorax. Br J Radiol 1993;66:1189-92.
  • Ruehm SG, Schroeder T, Debatin JF. Interstitial MR lymphography with gadoterate meglumine: Initial experience in humans. Radiology 2001;220:816-21.
  • Lindhorst E, Miller HA, Taylor GA, Gotzen L. On the possible role of positive end expiratory pressure ventilation in the treatment of chylothorax caused by blunt chest trauma. J Trauma 1998;44: 540-2.
  • Goto M, Kawamata K, Kitano M, Watanabe K, Chiba Y. Treatment of chylothorax in a premature infant using somatostatin. J Perinatol 2003;23:563-4.
  • Helin RD, Angeles ST, Bhat R. Octreotide therapy for chylothorax in infants and children: A brief review. Pediatr Crit Care Med 2006;7:576-9.
  • Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev 2010;9:CD006388.
  • Moreira-Pinto J, Rocha P, Osório A, Bonet B, Carvalho F, Duarte C, et al. Octreotide in the treatment of neonatal postoperative chylothorax: Report of three cases and literature review. Pediatr Surg Int 2011;27:805-9.
  • Azkur D, Yoldas T, Toyran M, Kocabas CN. A pediatric case of anaphylaxis due to octreotide. Asian Pac J Allergy Immunol 2011;29:361-3.
  • Guillem P, Billeret V, Houcke ML, Triboulet JP. Successful mana- gement of postesophagectomy chylothorax/chyloperitoneum by etilefrine. Dis Esophagus 1999;12:155-6.
  • Guillem P, Papachristos I, Peillon C, Triboulet JP. Etilefrine use in the management of postoperative chyle leaks in thoracic surgery. Interact Cardiovasc Thorac Surg 2004;3:156-60.
  • Soto-Martinez ME, Clifford V, Clarnette T, Ranganathan S, Massie RJ. Spontaneous chylothorax in a 2-year-old child. Med J Aust 2009;190:262-4.
  • Zanin A, Padalino MA, Cerutti A, Vida VL, Milanesi O, Stellin G, et al. Surgical ligation of cisterna chyli: An alternative treatment for chronic chylothorax in children. Ann Thorac Surg 2010;90:1732-4.
  • de Berranger E, Colinet S, Michaud L, Cremer R, Fourrier C, Brévière GM, et al. Severe selenium deficiency secondary to chylous loss. J Parenter Enteral Nutr 2006;30:173-4.
  • review of the literature. J Pediatr Hematol Oncol 2006;28:231-3.

Chylothorax in Childhood; Three Case Reports with Current Diagnosis and Treatment Approaches

Year 2015, Volume: 9 Issue: 3, 219 - 225, 01.08.2015

Abstract

Chylothorax is a rare cause of pleural effusion in childhood. Even though the etiology of the illness varies according to age, the major causes have been reported to be congenital causes, surgical procedures, trauma, tumoral factors, idiopathic and some infectious diseases. The three pediatric cases diagnosed as chylothorax with the help of clinical and radiological findings and pleural fluid analysis presented here include a 2.5-month-old female patient (idiopathic non-immune hydrops fetalis-associated congenital chylothorax), a 3.5-month-old male patient (idiopathic chylothorax) and an 11-month old male patient (idiopathic chylothorax). All three patients recovered with medical treatment (case 1; total parenteral nutrition and formula containing medium-chain fatty acids; case 2; total parenteral nutrition and formula containing medium chain fatty acids and somatostatin; case 3; formula containing medium chain fatty acids) supplemented by chest tube drainage. No recurrence was observed in any of the cases during the follow-up period. The diagnosis of chylothorax is made through clinical findings, radiology and the analysis of pleural fluid. In cases that fail to respond to treatment with diet and total parenteral nutrition, a successful outcome can be possible with the addition of somatostatin or octreotide treatment. Surgical treatment can be used in cases resistant to medical treatment

References

  • Eddiernan KA, Levine AB, Chitkara U, Berkowitz RL. Reliability of pleural fluid lymphocyte counts in the antenatal diagnosis of congenital chylothorax. Obstet Gynecol 1991;178:530-2.
  • Tutor JD. Chylothorax in Infants and Children. Pediatrics 2014;133:722-33.
  • Soto-Martinez M, Massie J. Chylothorax: Diagnosis and manage- ment in children. Paediatr Respir Rev 2009;10:199-207.
  • McGrath EE, Blades Z, Anderson PB. Chylothorax: Aetiology, diagnosis and therapeutic options. Respir Med 2010;104:1-8.
  • Paramés F, Freitas I, Fragata J, Trigo C, Pinto MF. Octreotide additional conservative therapy for postoperative chylothorax in congenital heart disease. Rev Port Cardiol 2009;28:799-807.
  • Chernick V, Reed MH. Pneumothorax and chylothorax in the neonatal period. J Pediatr 1970;76:624-32.
  • Fukushima K, Morokuma S, Fujita Y, Tsukimori K, Satoh S, Ochiai M, et al. Short-term and long-term outcomes of 214 cases of non- immune hydrops fetalis. Early Hum Dev 2011;87:571-5.
  • Çelik Y, Akbaş B, Mimaroğlu E, Taşkınlar H, Ali Arslanköylü AE, Hallıoğlu O. Hidrops fetalis ile birlikte nedeni bilinmeyen doğumsal şilotoraks. Çocuk 2013;13:70-2.
  • Faul JL, Berry GJ, Colby TV, Ruoss SJ, Walter MB, Rosen GD, et al. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med 2000;161:1037-46.
  • Higgins JN, Shah AR, Dicks-Mireaux CF, Conry BG. Case report: Computed tomography of generalized lymphangiomatosis and chylothorax. Br J Radiol 1993;66:1189-92.
  • Ruehm SG, Schroeder T, Debatin JF. Interstitial MR lymphography with gadoterate meglumine: Initial experience in humans. Radiology 2001;220:816-21.
  • Lindhorst E, Miller HA, Taylor GA, Gotzen L. On the possible role of positive end expiratory pressure ventilation in the treatment of chylothorax caused by blunt chest trauma. J Trauma 1998;44: 540-2.
  • Goto M, Kawamata K, Kitano M, Watanabe K, Chiba Y. Treatment of chylothorax in a premature infant using somatostatin. J Perinatol 2003;23:563-4.
  • Helin RD, Angeles ST, Bhat R. Octreotide therapy for chylothorax in infants and children: A brief review. Pediatr Crit Care Med 2006;7:576-9.
  • Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev 2010;9:CD006388.
  • Moreira-Pinto J, Rocha P, Osório A, Bonet B, Carvalho F, Duarte C, et al. Octreotide in the treatment of neonatal postoperative chylothorax: Report of three cases and literature review. Pediatr Surg Int 2011;27:805-9.
  • Azkur D, Yoldas T, Toyran M, Kocabas CN. A pediatric case of anaphylaxis due to octreotide. Asian Pac J Allergy Immunol 2011;29:361-3.
  • Guillem P, Billeret V, Houcke ML, Triboulet JP. Successful mana- gement of postesophagectomy chylothorax/chyloperitoneum by etilefrine. Dis Esophagus 1999;12:155-6.
  • Guillem P, Papachristos I, Peillon C, Triboulet JP. Etilefrine use in the management of postoperative chyle leaks in thoracic surgery. Interact Cardiovasc Thorac Surg 2004;3:156-60.
  • Soto-Martinez ME, Clifford V, Clarnette T, Ranganathan S, Massie RJ. Spontaneous chylothorax in a 2-year-old child. Med J Aust 2009;190:262-4.
  • Zanin A, Padalino MA, Cerutti A, Vida VL, Milanesi O, Stellin G, et al. Surgical ligation of cisterna chyli: An alternative treatment for chronic chylothorax in children. Ann Thorac Surg 2010;90:1732-4.
  • de Berranger E, Colinet S, Michaud L, Cremer R, Fourrier C, Brévière GM, et al. Severe selenium deficiency secondary to chylous loss. J Parenter Enteral Nutr 2006;30:173-4.
  • review of the literature. J Pediatr Hematol Oncol 2006;28:231-3.
There are 23 citations in total.

Details

Other ID JA62CG84KG
Journal Section Case Report
Authors

Yakup Canıtez This is me

Şükrü Çekiç This is me

Arif Gürpınar This is me

Nihat Sapan This is me

Publication Date August 1, 2015
Submission Date August 1, 2015
Published in Issue Year 2015 Volume: 9 Issue: 3

Cite

Vancouver Canıtez Y, Çekiç Ş, Gürpınar A, Sapan N. Chylothorax in Childhood; Three Case Reports with Current Diagnosis and Treatment Approaches. Türkiye Çocuk Hast Derg. 2015;9(3):219-25.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 6 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.